Inhibition by apomorphine of dopamine deamination in the rat brain.
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology*; D001479:Basal Ganglia / Q000187:drug effects / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism*; D001933:Brain Stem / Q000187:drug effects / Q000378:metabolism; D002250:Carbon Radioisotopes; D002394:Catechol O-Methyltransferase / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D006719:Homovanillic Acid / Q000378:metabolism; D007700:Kinetics; D008297:Male; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D010648:Phenylacetates / Q000378:metabolism; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D013997:Time Factors
D000963:Antimetabolites; D002250:Carbon Radioisotopes; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D002394:Catechol O-Methyltransferase; D001058:Apomorphine; D004298:Dopamine; D006719:Homovanillic Acid